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Available online 27 May 2011An investigation of the ethanolic extract from stems of Caesalpinia echinata Lam (Leguminosae-
Caesalpinioideae) led to the isolation of ﬁve new cassane diterpenes along with known
lambertianic acid. Their structures were determined based on spectroscopic methods. A
preliminary study on leishmanicidal activity demonstrated that compounds 1, 2 and 6 were
found to inhibit the growth of amastigote-like forms of Leishmania amazonensis without
affecting mononuclear cells obtained from human peripheral blood.
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Caesalpinia echinata Lam. belongs to the Leguminosae-
Caesalpinioideae family. It is a tropical tree that may reach up
to 30 m in height and blooms yellow ﬂowers from September
until December. The species originally had a wide distribution
in the Atlantic rainforest, ranging from Amazonas to São
Paulo, especially in the coasts of Pernambuco and Rio de
Janeiro [1]. Nowadays it is an endangered species [2] and it is
found only in 7% of the original Atlantic Forest [3].
The kernel has astringent and tonic properties [1], but there
are no pharmacological studies about C. echinata. Rezende et al.
[4] analyzed the volatile constituents of C. echinata by GC-MS.
E-β-ocimene was the major constituent of extracts obtained
from ﬂowers by a static cryogenic headspace while (E)-3-
hexen-1-olwas themajor constituent of extracts obtained from
leaves by hydrodistillation in a Clevenger apparatus.x: +55 31 32953115.
).
lsevier OA license. Previous investigations on species of the genus have
displayed interesting biological activities such as antidiabetic
[5], antiiﬂammatory [6], antiviral [7], antimalarial [8], anti-
microbial [9] and antiplasmodal [10]. As part of an investi-
gation of the chemical constituents of Caesalpinia echinatawe
report here the isolation and structure elucidation of ﬁve new
cassane diterpenes 1–5, and their preliminary evaluation of
leishmanicidal activities.
2. Experimental procedures
2.1. General experimental procedures
TLC analyses were conducted on pre-coated silica gel G-
60/F254 (0.25 mm, Merck) eluted with mixtures of CHCl3/
MeOH (65:50) and Hex/EtOAc (9:1). Spots were visualized
after spraying the plates with vanillin–H2SO4. Preparative
high speed co-current chromatography was carried out with
a CCC-1000 model (High Speed Countercurrent Chromato-
graph, Pharma-Tech Research Corp) equipped by two pumps
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phy (CCP) was carried out by Chromatotron 7924T model
(Harrison Research). Semi-preparative HPLC puriﬁcations
were carried out by a Shimadzu chromatograph, equipped
with a LC6AD pump and a dual wavelength detector (SPD10A),
using a Shim-pack®C18 column(5 μm,250×20 mmi.d.) eluted
with mixtures of MeCN/H2O at a ﬂow rate of 10 ml/min
and detection at 210 nm and 254 nm. Electron impact mass
spectrometry (EI-MS, 70 eV) was measured by Shimadzu
QP5050A spectrometer, equipped with a direct insertion
probe. Electrospray ionization mass spectrometry (ESI-MS)
was recorded on a Thermo Finnigan LCQ-Advantage spectrom-
eter. ESI-Q/ToFMS analyses were performed using a Q-ToF
MicroTM instrument (Micromass, Manchester, UK). Samples
were diluted in methanol/Milli-Q1water and introduced using
a syringe pumpwith ﬂow rates of 5–10 ml/min (electrospray).
UV spectra (200–400 nm) were obtained by Shimadzu SPDM-
10AVPDiodeArrayDetector. Infrared spectrawere obtained by
Shimadzu FTIR-8400 spectrometer, with the samples in KBr
pellets. 1H (400 MHz), 13CNMR (100 MHz), DEPT-135, COSY,
HMBC and NOESY experiments were carried out in a Bruker
DRX 400 spectrometer. Chemical shifts were recorded in δ
(ppm) using CDCl3 as solvent. Complete assignments of the 1H
and 13C chemical shifts of isolated compounds were solved by
interaction using the Perch NMR Software (University of
Kuopio, Finland). Conformational analyses were carried out
by Perch's molecular modeling system (MMS). 3D molecular
models were built with energetic optimization by Merck
Molecular Force Field (MMFF94) based on superior force ﬁelds.
2.2. Plant material
Stems of C. echinata were collected at Fundação Zoo-
Botânica, Belo Horizonte, Minas Gerais, Brazil, in March 2007.
A voucher specimen (BHZB 6458) in complete form with
ﬂowers was deposited at the Herbarium of Fundação Zoo-
Botânica of Belo Horizonte.
2.3. Extraction and isolation
Air-dried stems (55 g) of C. echinata were extracted with
EtOH under ultrasonication at room temperature. The solvent
was evaporated under reduced pressure to yield 1.6 g of
crude EtOH extract. The crude extract (1.5 g) was puriﬁed by
preparative high-speed co-current chromatography. The appa-
ratus was equipped with three polytetraﬂuoroethylene pre-
parative coils (total volume, 300 ml) and a 10 ml sample loop.
With the rotor stopped, the coils were ﬁlled with the lower
phase composition of a biphasic liquid system H2O/MeOH/
CH2Cl2 (4:6:5) at ﬂow rate of 6 ml/min. The coils were then
rotated at 1000 rpm and the upper phase was pumped in tail-
to-head direction, at a ﬂow rate of 4.5 ml/min. The extract
(1.5 g) was dissolved in 10 ml of the biphasic solvent mixture
and injected into the column. Lower phase was pumped at
3.0 ml/min and upper phase was pumped at 1.5 ml/min to give
22 fractions after TLC analysis. Fractions 17 and 18 (44 mg)
were subjected to semi-preparative reversed-phase HPLC with
MeCN:H2O 40:60→60:40 in 40 min, 60:40 in 10 min, at a ﬂow
rate of 10 ml/min, to yield 1 (2 mg), 2 (2.5 mg) and 3 (6.5 mg).
Fraction 19 (45 mg) was puriﬁed at the same conditions used
before and yielded the compounds 4 (2.5 mg) and 5 (2 mg).Fraction 20 (300 mg) was subjected to semi-preparative
circular chromatography on 1 mm plates of silica gel at a ﬂow
rate of 2–4 ml/min with hexane and ethyl acetate mixtures
to furnish 23 subfractions. Compound 6 (4 mg) was obtained
of subfractions 13–15 (18 mg) after column chromatography
(silica gel) with Hex/EtOAc mixtures. Compound (6, Fig. 1):
lambertianic acid, white powder; 1H NMR (CDCl3, 400 MHz): δ
0.61 (s, 3 H, CH3-20), 1.00–1.06 (m, 1 H, H-1a), 1.07–1.09, (m,
1 H,H-3a), 1.24 (br s, 3 H, CH3-19), 1.31 (dd, J=10.0 Hz, 5.0 Hz,
1 H, H-5), 1.47–1.56 (m, 1 H, H-2a), 1.54–1.62 (m, 1 H, H-9),
1.64–1.66 (m, 1 H, H-11a), 1.75 (td, J=9.0, 9.0, 4.0 Hz, 1 H, H-
11b), 1.79–1.86 (m, 1 H, H-1b),1.86–1.93 (m, 3 H, H-2b, H-6a
and H-7a), 1.97 (dd, J=11.0 Hz, 5.0 Hz, 1 H, H-6b), 2.15 (dd,
J=9.0, 4.0 Hz, 1 H,H-3b), 2.26 (dd, J=14.0, 9.0 Hz, 1 H,H-12a),
2.43 (dd, J=8.5, 3.0 Hz,1 H, H-7b), 2.56 (ddd, J=14.0, 9.0,
4.0 Hz, 1 H, H-12b), 4.58 (m, 1 H, H-17a), 4.89 (m, 1 H, J=1.9,
1.4 Hz, H-17b), 6.25 (m, 1 H, H-14), 7.19 (m, 1 H, H-16), 7.34
(m, 1 H, H-15), 10.57 (br s, 1 H, COO-H); 13C NMR (CDCl3,
100 MHz): δ 12.9 (C-20), 19.91 (C-2), 23.60 (C-12), 24.29 (C-
11), 26.09 (C-6), 28.99 (C-19), 38.03 (C-3), 38.71 (C-7), 39.07
(C-1), 40.39 (C-10), 44.13 (C-4), 55.27 (C-9), 56.24 (C-5),
106.53 (C-17), 110.97 (C-14), 125.47 (C-13), 138.75 (C-15)
142.69 (C-16) 147.84 (C-8), 182.08 (C-18); EI-MS m/z 316
([M]+), 279 (3), 223 (1.5), 167 (2.9), 149 (16), 139 (0.8), 104
(1), 88 (70), 70 (100), 61 (73).
2.4. Assay with Leishmania (Leishmania) amazonensis
Leishmanicidal activitywasdetermined against amastigote-
like forms that were obtained as previously described
by Callahan et al. [11] and cell viability was determined using
the methyl thiazolyl tetrazolium (MTT) assay described by
Teixeira et al. [12].
2.5. Lymphocyte proliferation assay
Peripheral blood mononuclear cells (PBMCs) were pre-
pared using the protocol previously described by Gazzinelli
et al. [13] and the cell proliferation was determined by the
MTT assay described by Jiang and Xu [14].
3. Results and discussion
As a part of an ongoing program devised for drug dis-
covery from natural products, the EtOH extract from stems of
C. echinata killed 94% of amastigotes-like forms of Leishmania
(Leishmania) amazonensis and presentedmoderate inhibitory
activity against human PBMC cells, stimulated with PHA, at
20 μg/ml (Table 3). The crude extract was fractionated by co-
current HSCCC, preparative reversed phase HPLC and silica
gel chromatography to give compounds 1–6 (Fig. 1).
Compound 1 was isolated as white amorphous powder
and gave a molecular ion peak at m/z 495 [M−H]− in the
negative ESI-MS spectrum and m/z 497.5985 [M+H]+in the
positive ESI-Q-TOF spectrum (calcd for C29H3707, 497.5999).
The UV spectrum exhibited absorption bands at 210 nm
and 279 nm, whereas the FT-IR (KBr) υmax spectrum showed
absorption bands at 3588, 2936, 2869, 1732, 1675, 1450,
1391, 1191 1144 and 950 cm−1. The 1H NMR spectrum of 1
(Table 1) showed resolved signals for one oleﬁnic proton at δ
5.72 (1 H, br s) that was assigned for H-15 ofα, β-unsaturated
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Fig. 1. Structure of compounds isolated from Caesalpinia echinata.
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and δ 1.08 (s), one secondary methyl group at δ 1.13 (d,
J=7.5 Hz) and two α and β-carbonilic methylene protons at
δ 2.96 and δ 2.64, respectively. One monosubstituted benzene
ring was assigned by resonances at δ 7.18–7.26. Most of the
methylene signals appeared as complex and overlapped
multiplet and were assigned by HSQC, HMBC and COSY
correlations (Table 1). The 13C NMR and DEPT-135 spectra
presented 29 carbon signals, eight quaternary including three
carbonyl (δ 181.60, 172.26, 170.16), two oleﬁnic carbons
(δ 172.17 and δ 140.15), one carbon of a hemiketal (δ 105.24)
and two others (C-4, δ 47.29 and C-10, δ 37.09). Also, these
spectra showed the presence of seven methylene carbons,
eleven methine carbons, comprising ﬁve aromatic carbons
(δ 128.50 (2x), 128.23 (2x), 126.39), one oleﬁnic carbon
(δ 113.68), and ﬁve methine carbons (δ 72.09, 49.25, 45.09,
35.87, 35.81), besides two tertiary methyl groups (δ 18.35,
17.63) and one secondary methyl group (δ 12.94). The 13C-
NMR spectrum revealed all signals consistent with the
structure of an α,β-butenolide hemiketal ring and hydro-
cinnamoyl ring moiety. The deshielded nature of the
carbon at δ 72.09 and the proton attached to it at δ 5.13 (br
d, J=3.0 Hz) suggested that the hydrocinnamoyl moiety is
attached to C-6. Small vicinal coupling constants values
between H-6 and H-5 (3J6eq,5ax=3.0 Hz) suggested an α-
equatorial hydrogen attached to C-6. Besides, H-6 methine
showed COSY and NOESY correlations to both vicinal proton
signals at C-7. Other NOESY correlations observed were
consistent with the conﬁguration proposed for compound 1.
NOESY correlations between H-6 and H-5 at δ 1.96 (br d,
J=3.0 Hz) and H-9 at δ 1.60 (m) suggested that protons were
on the same face. A double doublet at δ 2.76 (J=7.5 and
3.0 Hz) was assigned to H-14 coupled with both CH3-17
(δ 1.13 d, J=7.5 Hz) and an axial H-8 at δ 1.59 (m). H-14proton was depicted as β-equatorial based on NOESY cor-
relations and its small scalar coupling constant (3.0 Hz) with
H-8. From these data, compound 1 was identiﬁed as 6β-O-
2',3'-dihydrocinnamoyl-12-hydroxy-(13)15-en-16,12-olide-
18-cassaneoic acid.
Compound 2 was obtained as white amorphous powder
and it showed amolecular ion [M-H]- atm/z493 in the negative
ESI-MS and m/z 495.5800 [M+H]+in the positive ESI-Q-TOF
(calcd for C29H3507, 495.5841). The UV spectrum exhibited
absorption bands at 218 nm and 279 nm, whereas the F-TIR
(KBr) υmax spectrum showed absorption bands at 3459, 2939,
2869, 1690, 1440, 1400, 1209 and 1139 cm−1. The 1H and 13C
(Table 1) NMR spectroscopic data were closely related to those
of 1 except at C-6, where the dihydrocinnamoyl ester was
replaced by a cinnamoyl moiety (δ 6.38, d, J=16.0 Hz, H-2'
and δ 7.66, d, J=16.0 Hz, H-3'). The conﬁguration at C-6
was the same as in compound 1, since the coupling constants
of the associated protons were similar, and this was conﬁrmed
by NOESY experiments. Thus, compound 2 was established
as 6β-O-cinnamoyl-12-hydroxy-(13)15-en-16,12-olide-18-
cassaneoic acid.
Compound 3 was isolated as a white powder and the
negative ESI-MS showed a molecular ion [M-H]- at m/z 493
and exhibited fragment ions at m/z 179, suggesting the
presence of the caffeoyl ester moiety. It showed the
quasimolecular ion at m/z 495.5820 [M+H]+in the positive
ESI-Q-TOF (calcd for C29H3507, 495.5841). The UV spectrum
exhibited absorption bands at 220 nm, 309 nm and 327 nm,
whereas the FT-IR (KBr) υmax spectrum showed absorption
bands at 3423, 2939, 2869, 1704, 1514, 1450, 1269 and 1157
cm−1. A pair of doublets at δ 7.22 (d, J=1.9 Hz) and at δ 6.17
(d, J=1.9 Hz) in its 1H NMR spectrum (Table 2) suggested the
presence of a 2,3-disubstituted furan ring. The 1H NMR spec-
trum revealed the presence of two terciarymethyl groups at δ
Table 1
NMR spectroscopic data of the compounds 1 and 2 (1H NMR, 400 MHz; 13C NMR,100 MHz, CDCl3; δ in ppm, multiplicities, J in Hz).
1 2
Position δH (mult. J, Hz) δC DEPT COSY HMBC NOESY δH (mult. J, Hz) δC DEPT COSY HMBC
1eq(β) 1.78m 41.03 1α, 2α 3, 9 1α, 11α 1.84 m 41.09 1α, 2α 3
1ax(α) 1.18 ddd (12.8, 12.8, 5.0) 1β 1β 1.25 m 1β 5, 10
2ax(β) 1.61 m 17.97 5, 10 19β 1.66 m (2H) 17.96 1α, 1β, 3α, 3β 19
2eq(α) 1.58 m 1β
3eq(β) 1.76 dd (12.8, 3.0) 39.00 2α 5, 20 1β 1.79 m 39.05 2β 19
3ax(α) 1.69 dd (12.8, 5.0) 2β 1 1.70 m 1β, 3β 1, 4, 5
4 47.29 5, 19 47.41 5, 19
5ax(α) 1.96 br d (3.0) 49.25 6α 2, 4, 10, 18, 20 6α, 3α 2.10 br d (1.8) 49.41 6α, 7α 2, 4, 10
6eq(α) 5.13 br d (3.0) 72.09 5α, 7α 5α, 7α, 9α, 19β 5.30 td (3.0, 1.8, 1.8) 72.12 5α, 7α, 7β
7 1.61 m (2H) 34.95 6α 8, 17 6α 1.86 m 35.17 6α, 7α, 9α
1.73 m 6α, 7β 8
8ax(β) 1.59 m 35.81 9α, 14β 17 14β 1.96 ddd (10.0, 6.0, 3.0) 36.15 14β, 7α, 9α 17
9ax(α) 1.60 m 45.09 8β, 11α 5 6α 1.75 m 45.18 8β,11β, 11α 20
10 37.09 5 37.25 5, 20
11ax(β) 1.37 d (13.0) 37.57 11α 20 8β, 11β 1.49 d (13.0) 37.68 9α, 11α 20
11eq(α) 2.39 dd (13.0, 3.0) 11β 1β, 11α 2.47 dd (13.0, 3.0) 9α, 11β 8, 20
12 105.24 15 105.31 15
13 172.17 17 172.31 17
14β 2.76 dd (7.5, 3.0) 35.87 8β, 17α 17 17α 2.94 dd (7.0, 5.0) 35.96 9α, 17 17
15 5.72, br s 113.68 12, 16 14β 5.72 br s 113.72 12, 16
16 170.16 15 170.25 15
17α 1.13. d (7.5, 3H) 12.94 14β 8, 13, 14, 16 14β 1.19 d (7.0, 3H) 12.96 14β 8, 13, 14
18 181.60 19 182.20 19
19β 1.32 s (3H) 18.35 5α 3, 5, 18 20 1.39 s (3H) 18.38 3β 3, 4, 10, 18
20β 1.08 s (3H) 17.63 5α 1, 5, 9, 10 19 1.26 s (3H) 18.02 11β 1, 5, 9, 10
1' 172.26 166.27 3'
2' 2.64 td (2× 7.5, 3.0, 2H) 36.30 3' 6.38 d (16.0, 2H) 118.30 3' 4'
3' 2.96 td (2× 7.5, 3.0, 2H) 30.85 5´, 9´ 5', 9' 2' 7.66 d (16.0, 2H) 145.28 2' 1', 5', 9'
4' 140.15 3', 6', 8' 134.18 2'
5' 7.19 m 128.23 3´, 7´ 7', 9' 6' 7.52 (m) 128.15 6' 3', 8'
6' 7.27 m 128.50 8´ 4', 8' 5', 7' 7.39 (m) 128.94 5' 5', 9'
7' 7.18 m 126.39 5´, 9´ 5', 9' 6', 8' 7.40 (m) 130.53 5',9' 5', 6', 8', 9'
8' 7.26 m 128.50 6´ 4', 6' 9', 7' 7.39 (m) 128.94 7' 5', 9'
9' 7.19 m 128.23 5´, 7´ 5', 7' 8' 7.52 (m) 128.15 8' 3', 6'
972 B.B. Cota et al. / Fitoterapia 82 (2011) 969–9751.47 and 1.37 and one secondary methyl group at δ 0.97 (d,
J=7.0 Hz), ﬁve aliphatic methylenes (δ 1.79 and 1.23, 1.69
and 1.60, 1.86 and 1.73, 1.96 and 1.73, 2.65 and 2.52) and ﬁve
aliphatic methines (δ 5.40, 2.57, 2.21, 2.09, 1.72). A caffeoyl
ester ring moiety was conﬁrmed by signals of aromatic
protons found at δ 6.88–7.11, and two coupled doublets at δ
7.55 (J=15.8 Hz) and at δ 6.17 (J=15.8 Hz) assigned for
oleﬁnic protons. Moreover, the 13C NMR and DEPT-135 of 3
(Table 2) showed a total of 29 carbon signals, nine quaternary
represented by two carbonyl (δ 181.06, 166.66) and ﬁve
oleﬁnic carbons that includes two furan carbons (δ 149.44
and 122.01) and three aromatic carbons (δ 148.34, 145.80
and 126.33). These spectra showed the presence of ﬁve
methylene carbons (δ 41.39, 18.22, 39.00, 35.87, 21.44),
twelve methine carbons, comprising three aromatic carbons
(δ 121.34, 115.12 and 113.99), two furan oleﬁnic carbons (δ
140.16 and 109.26), two oleﬁnic carbons in caffeoyl ester
moiety (δ 144.80 and 115.29) and ﬁve others (C-5, δ 49.72, C-
6, δ 72.14, C-8, δ 31.19, C-9, δ 45.58, C-14, δ 30.87). In addition,
13C-NMR spectrum of 3 revealed the signals of two tertiary
methyl groups (δ 17.99, 17.72) and one secondary methyl
group (δ 17.44). The conﬁguration of compound 3 was
determined by analysis of coupling constants and NOESY
data. The small coupling constant between H-5 at δ 2.21 (br
d, J=2.0 Hz) and H-6 at δ 5.40 (br d, J=2.0 Hz) indicated
that H-6 is at α-equatorial position. In the NOESY spectrumH-6 had cross-peaks with H-5 and H-5 with H-9, conﬁrmed
that H-5 was axial and that the C-6 was equatorial. These
observations allowed for 3 to be proposed as being 6β-O-6',7'
dihydroxycinnamoyl-18-vouacapaneoic acid.
Compound 4 showed themolecular ion [M-H]− atm/z 480 in
negative ESI-MS spectrum and m/z 479.5805 [M−H]− in the
negative ESI-Q-TOF (calcd for C29H3706, 479.5845). The UV
spectrum exhibited absorption bands at 218 nm, 309 nm and
327 nm, whereas the FT-IR (KBr) υmax spectrum showed
absorption bands at 3441, 2929, 2855, 1695, 1518, 1446, 1382,
1273 and 1177 cm−1. The 1H and 13C NMR spectral data
(Table 2) of 4 revealed the same cassane-type skeleton as 3
which contains a furan and a 6',7'-dihydroxy-trans-cinnamoyl
moieties. The major difference was the replacement of the acid
carboxilic group by a hydroxymethylene group at C-18. The 1H-
NMR spectrum presented two coupled doublets at δ 3.64
( J=11.0 Hz) and at δ 3.18 ( J=11.0 Hz), and the 13C-NMR
spectrum showed an oxygenated carbon signal at δ 71.6
corresponding to hydroxymethylene group. The hydroxymethyl
proton H-18A at δ 3.18 showed HMBC correlation with carbon
signal ofmethyl group (C-19), andH-19 andH-20 showedHMBC
correlations with C-18. Thus, the structure of compound 4 was
determined as 6β-O-cinnamoyl-18-vouacapaneol.
Compound 5 exhibitedmolecular peak [M+H]+ atm/z 333
by positive ESI-MS andm/z 331.4198 [M−H]− in the negative
ESI-Q-TOF (calcd for C20H2706, 331.4259). The UV spectrum
Table 2
NMR spectroscopic data of the compounds 3–5 (1H NMR, 400 MHz; 13C NMR,100 MHz, CDCl3; δ in ppm, multiplicities, J in Hz).
3 4 5
Position δ (mult. J, z) δC DEPT COSY HMBC NOESY δ (mult. J, z) δC DEPT COSY HMBC δ (mult. J, z) δC DEPT COSY HMBC
1eq(β) 1.79 d (12.5) 41.39 1α 3, 10, 20 1α 1.76 br d (13.0) 41.72 3β 3, 20 1.72 m 41.44 5α, 20β 9, 10
1ax(α) 1.23 dd (12.5, 4.0) 2β 1β 1.11 dt (13.0,
13.0, 3.0)
2β, 3a, 20 2 1.18 ddd (12.5,
12.5, 4.0)
1β, 2β
2ax(β) 1.69 m 18.22 3β, 5α 5, 19 11β 1.72 m 18.17 1β, 2α 1 1.59 m 18.06 2α
2eq(α) 1.60 dd (13.0, 3.0) 3β 2β 1.55 dd (14.0, 4.0) 1β, 2β 1.69 m 2β
3eq(β) 1.86 dd (13.0, 4.0) 39.00 3α 1, 5, 19 19 1.69 m 37.08 2α, 3α 5, 19 1.69 m 40.40 19
3ax(α) 1.73 m 3β 5α 1.22 m 2β, 3β
4 47.23 5, 19 38.31 5, 19 47.98 5, 7
5ax(α) 2.21 br d (2.0) 49.72 7β, 3α 2, 4, 9, 10, 18, 19 7α, 9α 1.75 m 48.40 6α 4, 9, 20 1.85 br s 50.73 6α 1
6eq(α) 5.40 br d (2.0) 72.14 5α, 7α, 7β 8, 10 5α, 7α, 7β 5.60 ddd (4.0, 3.0, 3.0) 69.73 5α, 7α, 9α 4.15 m 70.18 5α, 7β, 7α
7(β) 1.96 td (14.0,
3.0, 3.0)
35.87 7β, 8β 14 2.34 m 36.46 9α 1.80 ddd (13.0,
13.0, 4.0)
38.74 6α, 7α
7(α) 1.73 m 7β, 8β 5, 8 6α 1.88 ddd (14.0, 3.0, 3.0) 8β 5, 8 1.69 m 7β
8ax(β) 2.09 m 31.19 7α, 7β 6, 11 11β, 14β, 20 2.10 m 31.12 7α, 9α 7, 11 2.18 m 30.70 7α, 7β, 9α
9ax(α) 1.72 m 45.58 11α, 11β 5, 11, 20 6α, 11α, 17 1.64 m 45.67 6β, 7β, 11β, 14β 20 1.62 m 46.22 8β, 11β 1, 10, 20
10 37.26 1, 5, 6, 11, 20 37.78 5, 20 37.25 5, 20
11ax(β) 2.52 dd (17.0, 10.0) 21.44 9α 8, 9, 10, 12, 13, 20 1β 2.52 m 21.80 8 2.48 dd (16.0, 10.0) 21.71 11β 12
11eq(α) 2.65 dd (17.0, 6.5) 9α 9α, 1α 2.65 ddd (15.0,
15.0, 7.0)
7α, 9α, 11β 2.61 dd (16.0, 7.0) 9α, 11α
12 149.44 11, 15, 16 149.45 11 149.35 11
13 122.01 11, 15, 16, 17 122.55 11 122.27 15
14β 2.57 dd (7.0, 5.0) 30.87 17 12, 13, 17 7β, 8β, 17 2.57 m 31.14 8β, 17 12, 17 2.61 m 31.26 17α 13
15 6.17 d (1.9) 109.26 16 12, 13, 16 16 6.18 d (1.8) 109.49 16 16 6.19 d (2.0) 109.52 16 15
16 7.22 d (1.9) 140.16 15 15 15 7.23 d (1.8) 140.44 15 15 7.23 d (2.0) 140.45 15 13
17α 0.97 d (7.0) 17.44 14β, 8β, 9α 12, 13, 14 9α, 14β, 15, 0.92 d (7.0, 3H) 17.60 14 8, 13, 14 0.98 d (7.0, 3H) 18.06 14β 8
18B 181.06 3, 4, 5, 19 3.64 d (11.0) 71.60 18A 183.59 19
18A 3.18 d (11.0) 18B 19
19β 1.47 s (3H) 17.99 3β, 20 1, 3, 4, 5, 18 3β, 6α 0.96 s (3H) 19.56 3, 4, 5, 18 1.62 s (3H) 18.87 3, 5, 18
20β 1.37 s (3H) 17.72 19 1, 5, 9, 10 1β, 2β, 8β, 2' 1.34 s (3H) 18.07 1α 1, 5, 9, 10, 18 1.27 s (3H) 17.84 1, 5, 9, 10
1' 166.66 2', 3', 5', 9' 167.18 3'
2' 6.17 d (15.8) 115.29 3' 3', 5', 9' 5', 9', 20 6.22 d (16.0) 116.62 3' 4'
3' 7.55 d (15.8) 144.80 2' 5', 7', 9' 5', 9', 20 7.54 d (16.0) 145.24 2' 1',5'
4' 126.33 2', 8' 127.70 2', 8'
5' 7.11 d (1.9) 113.99 9' 3', 9' 2', 3' 7.07 d (2.0) 114.30 8', 9' 3', 7', 9'
6' 145.80 5', 8' 146.19 4, 8'
7' 148.34 5', 9' 148.77 5'
8' 6.88 d (8.0) 115.12 9' 4', 6' 9' 6.86 d (8.5) 115.52 5' 4', 6'
9' 6.92 d (8.0, 1.9) 121.34 8' 3', 5' 2', 3' 6.99 dd (8.5, 2.0) 121.64 5' 4', 5'
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Table 3
Results of the biological assays of the isolated compounds.
Compounds* % Leishmanicidal
activitya
%Inhibition of PBMC
proliferationb
1 56±13 114±8
2 69±8 112±37
3 26±19 124±13
4 43±21 –
5 27±0 122±12
6 62±9 120±28
EtOH extract 94±6 60±5
AMB** 70±10 –
DMSO*** 6±2 100
*Extract and compoundswere tested at 20 μg/ml. **AmphotericinB at 0.2 μg/m
was used as positive drug control. ***DMSO was tested at 0.1% v/v. (–) no
tested.
a Amastigote-like forms of Leishmania (Leishmania) amazonensis.
b Human peripheral blood mononuclear cells, stimulated with PHA.
974 B.B. Cota et al. / Fitoterapia 82 (2011) 969–975exhibited absorption bands at 220 nm and 279 nm, whereas
the FT-IR (KBr) υmax spectrum showed absorption bands
at 3441, 2930, 2871, 1695, 1459, 1395, 1199 and 1172 cm−1.
The 1H NMR spectrum (Table 2) exhibited signals of two
tertiary methyl groups at δ 1.62 (s) and δ 1.27 (s), and a
secondarymethyl group at δ 0.98 (d, J=7.0 Hz). In the lowﬁeld
regionof the spectrum, twoprotons of a 1,2-disubstituted furan
resonated at δ 7.23 (d, J=2.0 Hz, H-16) and at δ 6.19 (d,
J=2.0 Hz, H-15). Analysis of the 13C NMR and DEPT-135
spectra of 5 revealed signals of one carbonyl at δ 183.59, four
carbons of the furan ring (δ 149.35, 140.45, 122.27, 109.52) and
one oxygenated carbon at δ 70.18. One oxymethine proton at δ
4.15 (m)was assigned forH-6 that showedcorrelationswithH-
5 and H-7 in the COSY experiment. The conﬁgurations of
compound 5were the same as in compound 3 and 4 and it was
identiﬁed as 6β-hydroxi-18-vouacapaneoic acid.
Compound 6 exhibited molecular peak at m/z 316 ([M]+)
by EI-MS suggesting the molecular formula C20H28O3. All the
spectroscopic data observed for compound 6 were identical
to those described for lambertianic acid [15].
Compounds 1 and 2 can be considered as derivatives from
vinhaticoic acid, a furanocassane-type diterpene isolated from
Dipteryx lacunifera Ducke (Leguminosae-Papilionoideae), a
species that occurs in Brazil [16]. Previous studies on species
of this genus reported the same skeletonwith amethine on C-5
[17–21]. Compounds1–5 are cassane diterpenes with trans-
cinnamoyl or trans-hydrocinnamoyl groups as side chain atC-6.
The relative conﬁguration of compounds 1–5 was deﬁned by
NOESY results and built with energy-minimized conformation
(Fig. 2). All structures adopt trans-junction of the three
hexagonal rings and the trans-cinnamoyl ester groups were
placed on opposite face of COOH groups.1 3
42
5
6
Fig. 2. Conformational analyses of compounds 1–6 by PERCH NMR software.l
tCompounds 1, 2 and 6 were tested against Leishmania
(Leishmania) amazonensis (Table 3) and neither of them is
more active than the crude extract, but they are not toxic to
human peripheral blood mononuclear cells in vitro at a
concentration of 20 μg/ml. In this paper, we reported for the
ﬁrst time, the isolation and elucidation of furan and hemiketal
cassane-type diterpenes and also the evaluation of their
leishmanicidal activity.
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